ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P04839


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name CY24B_HUMAN
Primary accession number P04839
Secondary accession number Q2PP16
Integrated into Swiss-Prot on August 13, 1987
Sequence was last modified on January 23, 2007 (Sequence version 2)
Annotations were last modified on    November 25, 2008 (Entry version 101)
Name and origin of the protein
Protein name Cytochrome b-245 heavy chain
Synonyms EC 1.-.-.-
p22 phagocyte B-cytochrome
Neutrophil cytochrome b 91 kDa polypeptide
Heme-binding membrane glycoprotein gp91phox
CGD91-phox
gp91-phox
gp91-1
Cytochrome b(558) subunit beta
Cytochrome b558 subunit beta
Superoxide-generating NADPH oxidase heavy chain subunit
NADPH oxidase 2
Gene name
Name: CYBB
Synonyms: NOX2
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=2425263 [NCBI, ExPASy, EBI, Israel, Japan]
Royer-Pokora B., Kunkel L.M., Monaco A.P., Goff S.C., Newburger P.E., Baehner R.L., Cole F.S., Curnutte J.T., Orkin S.H.;
"Cloning the gene for an inherited human disorder -- chronic granulomatous disease -- on the basis of its chromosomal location.";
Nature 322:32-38(1986).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS X-CGD ASP-41 AND ARG-537, AND VARIANTS ARG-364 AND GLU-517.
DOI=10.1006/clim.2002.5230; PubMed=12139950 [NCBI, ExPASy, EBI, Israel, Japan]
Jirapongsananuruk O., Niemela J.E., Malech H.L., Fleisher T.A.;
"CYBB mutation analysis in X-linked chronic granulomatous disease.";
Clin. Immunol. 104:73-76(2002).
[3]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
NHLBI resequencing and genotyping service (RS&G);
Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Lymph;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[5]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-135.
DOI=10.1038/327717a0; PubMed=3600768 [NCBI, ExPASy, EBI, Israel, Japan]
Dinauer M.C., Orkin S.H., Brown R., Jesaitis A.J., Parkos C.A.;
"The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex.";
Nature 327:717-720(1987).
[6]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 233-267.
TISSUE=Peripheral blood;
DOI=10.1006/geno.1998.5510; PubMed=9790760 [NCBI, ExPASy, EBI, Israel, Japan]
Kumatori A., Faizunnessa N.N., Suzuki S., Moriuchi T., Kurozumi H., Nakamura M.;
"Nonhomologous recombination between the cytochrome b558 heavy chain gene (CYBB) and LINE-1 causes an X-linked chronic granulomatous disease.";
Genomics 53:123-128(1998).
[7]
PROTEIN SEQUENCE OF 2-44.
DOI=10.1038/327720a0; PubMed=3600769 [NCBI, ExPASy, EBI, Israel, Japan]
Teahan C., Rowe P., Parker P., Totty N., Segal A.W.;
"The X-linked chronic granulomatous disease gene codes for the beta-chain of cytochrome b-245.";
Nature 327:720-721(1987).
[8]
CHARACTERIZATION AS A PROTON CHANNEL.
PubMed=10578014 [NCBI, ExPASy, EBI, Israel, Japan]
Henderson L.M., Meech R.W.;
"Evidence that the product of the human X-linked CGD gene, gp91-phox, is a voltage-gated H(+) pathway.";
J. Gen. Physiol. 114:771-786(1999).
[9]
VARIANT X-CGD HIS-415.
PubMed=2556453 [NCBI, ExPASy, EBI, Israel, Japan]
Dinauer M.C., Curnutte J.T., Rosen H.R., Orkin S.H.;
"A missense mutation in the neutrophil cytochrome b heavy chain in cytochrome-positive X-linked chronic granulomatous disease.";
J. Clin. Invest. 84:2012-2016(1989).
[10]
VARIANTS X-CGD ARG-101; THR-156; TYR-209; SER-244 AND ALA-389.
PubMed=1710153 [NCBI, ExPASy, EBI, Israel, Japan]
Bolscher B.G.J.M., de Boer M., de Klein A., Weening R.S., Roos D.;
"Point mutations in the beta-subunit of cytochrome b558 leading to X-linked chronic granulomatous disease.";
Blood 77:2482-2487(1991).
[11]
VARIANT X-CGD GLU-57.
DOI=10.1007/BF01955051; PubMed=8101486 [NCBI, ExPASy, EBI, Israel, Japan]
Ariga T., Sakiyama Y., Tomizawa K., Imajoh-Ohmi S., Kanegasaki S., Matsumoto S.;
"A newly recognized point mutation in the cytochrome b558 heavy chain gene replacing alanine57 by glutamic acid, in a patient with cytochrome b positive X-linked chronic granulomatous disease.";
Eur. J. Pediatr. 152:469-472(1993).
[12]
VARIANT X-CGD HIS-339.
DOI=10.1007/BF00201609; PubMed=7927345 [NCBI, ExPASy, EBI, Israel, Japan]
Ariga T., Sakiyama Y., Matsumoto S.;
"Two novel point mutations in the cytochrome b 558 heavy chain gene, detected in two Japanese patients with X-linked chronic granulomatous disease.";
Hum. Genet. 94:441-441(1994).
[13]
VARIANT X-CGD GLY-500.
PubMed=8182143 [NCBI, ExPASy, EBI, Israel, Japan]
Leusen J.H.W., de Boer M., Bolscher B.G.J.M., Hilarius P.M., Weening R.S., Ochs H.D., Roos D., Verhoeven A.J.;
"A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.";
J. Clin. Invest. 93:2120-2126(1994).
[14]
VARIANTS X-CGD ILE-205; PHE-215 DEL AND GLN-342.
PubMed=8916969 [NCBI, ExPASy, EBI, Israel, Japan]
Hui Y.F., Chan S.Y., Lau Y.L.;
"Identification of mutations in seven Chinese patients with X-linked chronic granulomatous disease.";
Blood 88:4021-4028(1996).
[15]
ERRATUM.
Hui Y.F., Chan S.Y., Lau Y.L.;
Blood 89:1843-1843(1996).
[16]
VARIANT X-CGD PHE-215 DEL.
PubMed=9111587 [NCBI, ExPASy, EBI, Israel, Japan]
Jendrossek V., Ritzel A., Neubauer B., Heyden S., Gahr M.;
"An in-frame triplet deletion within the gp91-phox gene in an adult X-linked chronic granulomatous disease patient with residual NADPH-oxidase activity.";
Eur. J. Haematol. 58:78-85(1997).
[17]
VARIANTS X-CGD ARG-20; SER-54; ARG-59; ARG-119; THR-156; GLN-209; ASN-222; ARG-222; TYR-222; LEU-223; ARG-244; LYS-309; LYS-315 DEL; GLU-322; PHE-325; PRO-333; HIS-339; PRO-356; ARG-405; GLU-408; ARG-408; HIS-415; LEU-415; PRO-422; ARG-453; CYS-516; ASP-534 AND ARG-537.
DOI=10.1086/301874; PubMed=9585602 [NCBI, ExPASy, EBI, Israel, Japan]
Rae J., Newburger P.E., Dinauer M.C., Noack D., Hopkins P.J., Kuruto R., Curnutte J.T.;
"X-linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase.";
Am. J. Hum. Genet. 62:1320-1331(1998).
[18]
VARIANT X-CGD TYR-101.
DOI=10.1007/s004390050836; PubMed=9856476 [NCBI, ExPASy, EBI, Israel, Japan]
Tsuda M., Kaneda M., Sakiyama T., Inana I., Owada M., Kiryu C., Shiraishi T., Kakinuma K.;
"A novel mutation at a probable heme-binding ligand in neutrophil cytochrome b558 in atypical X-linked chronic granulomatous disease.";
Hum. Genet. 103:377-381(1998).
[19]
VARIANTS X-CGD ARG-179 AND 298-THR--THR-302 DEL.
PubMed=9794433 [NCBI, ExPASy, EBI, Israel, Japan]
Dusi S., Nadalini K.A., Donini M., Zentilin L., Wientjes F.B., Roos D., Giacca M., Rossi F.;
"Nicotinamide-adenine dinucleotide phosphate oxidase assembly and activation in EBV-transformed B lymphoblastoid cell lines of normal and chronic granulomatous disease patients.";
J. Immunol. 161:4968-4974(1998).
[20]
VARIANTS X-CGD MET-54; ASP-55; GLU-57; HIS-339 AND PHE-344.
DOI=10.1203/00006450-199807000-00014; PubMed=9667376 [NCBI, ExPASy, EBI, Israel, Japan]
Ariga T., Furuta H., Cho K., Sakiyama Y.;
"Genetic analysis of 13 families with X-linked chronic granulomatous disease reveals a low proportion of sporadic patients and a high proportion of sporadic carriers.";
Pediatr. Res. 44:85-92(1998).
[21]
VARIANTS X-CGD PHE-193; ARG-222; TYR-338; HIS-339 AND PRO-546, AND VARIANT ARG-364.
PubMed=10089913 [NCBI, ExPASy, EBI, Israel, Japan]
Roesler J., Heyden S., Burdelski M., Schaefer H., Kreth H.-W., Lehmann R., Paul D., Marzahn J., Gahr M., Roesen-Wolff A.;
"Uncommon missense and splice mutations and resulting biochemical phenotypes in German patients with X-linked chronic granulomatous disease.";
Exp. Hematol. 27:505-511(1999).
[22]
VARIANTS X-CGD VAL-225 AND TYR-244.
DOI=10.1002/(SICI)1098-1004(1999)13:1<29::AID-HUMU3>3.0.CO;2-X; PubMed=9888386 [NCBI, ExPASy, EBI, Israel, Japan]
Patino P.J., Perez J.E., Lopez J.A., Condino-Neto A., Grumach A.S., Botero J.H., Curnutte J.T., Garcia de Olarte D.;
"Molecular analysis of chronic granulomatous disease caused by defects in gp91-phox.";
Hum. Mutat. 13:29-37(1999).
[23]
VARIANTS X-CGD MET-54; ASP-55; GLU-57; TYR-101; ARG-209; GLY-224; LYS-309; TYR-338; HIS-339; PHE-344; GLU-389; PRO-420 AND ARG-516.
DOI=10.1007/s004390000288; PubMed=10914676 [NCBI, ExPASy, EBI, Israel, Japan]
Ishibashi F., Nunoi H., Endo F., Matsuda I., Kanegasaki S.;
"Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency.";
Hum. Genet. 106:473-481(2000).
[24]
VARIANTS X-CGD 54-ARG-ALA-55 DEL; TRP-59; PRO-307 AND ARG-505.
DOI=10.1002/humu.1166; PubMed=11462241 [NCBI, ExPASy, EBI, Israel, Japan]
Gerard B., El Benna J., Alcain F., Gougerot-Pocidalo M.-A., Grandchamp B., Chollet-Martin S.;
"Characterization of 11 novel mutations in the X-linked chronic granulomatous disease (CYBB gene).";
Hum. Mutat. 18:163-163(2001).
[25]
VARIANTS X-CGD ASN-303 AND ARG-304.
DOI=10.1016/S0925-4439(01)00110-7; PubMed=11997083 [NCBI, ExPASy, EBI, Israel, Japan]
Stasia M.J., Lardy B., Maturana A., Rousseau P., Martel C., Bordigoni P., Demaurex N., Morel F.;
"Molecular and functional characterization of a new X-linked chronic granulomatous disease variant (X91+) case with a double missense mutation in the cytosolic gp91phox C-terminal tail.";
Biochim. Biophys. Acta 1586:316-330(2002).
[26]
CHARACTERIZATION OF VARIANTS X-CGD ASN-303 AND ARG-304.
DOI=10.1007/s00439-004-1173-z; PubMed=15338276 [NCBI, ExPASy, EBI, Israel, Japan]
Bionda C., Li X.J., van Bruggen R., Eppink M., Roos D., Morel F., Stasia M.-J.;
"Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells.";
Hum. Genet. 115:418-427(2004).
Comments
  • FUNCTION: Critical component of the membrane-bound oxidase of phagocytes that generates superoxide. It is the terminal component of a respiratory chain that transfers single electrons from cytoplasmic NADPH across the plasma membrane to molecular oxygen on the exterior. Also functions as a voltage-gated proton channel that mediates the H(+) currents of resting phagocytes. It participates in the regulation of cellular pH and is blocked by zinc.
  • COFACTOR: FAD (Probable).
  • SUBUNIT: Composed of a heavy chain (beta) and a light chain (alpha).
  • SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
  • PTM: Glycosylated.
  • DISEASE: Defects in CYBB are a cause of X-linked chronic granulomatous disease (X-CGD) [MIM:306400]. X-CGD is characterized by the failure of activated phagocytes to generate superoxide. Patients suffer from life-threatening bacterial/fungal infections. Patients with CYBB dysfunction are generally classified into three groups, namely X91(0) (no expression of the protein); X91(-) (reduced expression) and X91(+) (normal expression).
  • SIMILARITY: Contains 1 FAD-binding FR-type domain.
  • SIMILARITY: Contains 1 ferric oxidoreductase domain.
  • SEQUENCE CAUTION:
    • Sequence=CAA29327.1; Type=Erroneous gene model prediction;
  • WEB RESOURCE: Name=CYBBbase; Note=CYBB deficiency database; URL="http://bioinf.uta.fi/CYBBbase/";.
  • WEB RESOURCE: Name=GeneReviews; URL="http://www.genetests.org/query?gene=CYBB";.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
X04011; CAA27635.1; ALT_INIT; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF469769; AAL76082.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF469757; AAL76082.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF469758; AAL76082.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF469759; AAL76082.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF469760; AAL76082.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF469761; AAL76082.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF469762; AAL76082.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF469763; AAL76082.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF469764; AAL76082.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF469765; AAL76082.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF469766; AAL76082.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF469767; AAL76082.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF469768; AAL76082.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
DQ314869; ABC40728.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC032720; AAH32720.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
X05895; CAA29327.1; ALT_SEQ; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AB013904; BAA34183.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
PIR S70773; S70773.
RefSeq NP_000388.2; -.
UniGene Hs.292356
3D structure databases
ModBase P04839.
Protein family/group databases
PeroxiBase 5962; HsNOx02.
Organism-specific databases
H-InvDB HIX0016724; -.
HGNC HGNC:2578; CYBB.
GenAtlas CYBB.
MIM 300481; gene. [NCBI / EBI]
306400; phenotype. [NCBI / EBI]
Orphanet 379; Granulomatous disease, chronic.
PharmGKB PA27076; -.
GeneCards P04839.
Gene expression databases
ArrayExpress P04839; -.
CleanEx HS_CYBB; -.
GermOnline ENSG00000165168; Homo sapiens.
Ontologies
GO
GO:0043020; Cellular component: NADPH oxidase complex (inferred from direct assay from UniProtKB).
GO:0009055; Molecular function: electron carrier activity (inferred from electronic annotation from InterPro).
GO:0050660; Molecular function: FAD binding (inferred from electronic annotation from InterPro).
GO:0020037; Molecular function: heme binding (inferred from mutant phenotype from UniProtKB).
GO:0005506; Molecular function: iron ion binding (inferred from electronic annotation from InterPro).
GO:0046982; Molecular function: protein heterodimerization activity (inferred from physical interaction from UniProtKB).
GO:0016175; Molecular function: superoxide-generating NADPH oxidase activity (traceable author statement from UniProtKB).
GO:0005244; Molecular function: voltage-gated ion channel activity (inferred from electronic annotation from UniProtKB-KW).
GO:0022900; Biological process: electron transport chain (inferred from electronic annotation from UniProtKB-KW).
GO:0006954; Biological process: inflammatory response (traceable author statement from ProtInc).
GO:0045087; Biological process: innate immune response (inferred from mutant phenotype from UniProtKB).
GO:0006811; Biological process: ion transport (inferred from electronic annotation from UniProtKB-KW).
GO:0045730; Biological process: respiratory burst (inferred from mutant phenotype from UniProtKB).
GO:0042554; Biological process: superoxide release (inferred from direct assay from UniProtKB).
QuickGo view.
Family and domain databases
InterPro IPR013112; FAD_bd_8.
IPR013130; Fe3_reduct_TM_N.
IPR013121; Fe_red_NAD_bd_6.
IPR000778; GP91PhoX.
Graphical view of domain structure.
Pfam PF08022; FAD_binding_8; 1.
PF01794; Ferric_reduct; 1.
PF08030; NAD_binding_6; 1.
Pfam graphical view of domain structure.
PRINTS PR00466; GP91PHOX.
PROSITE PS51384; FAD_FR; 1.
PROSITE graphical view of domain structure (profiles).
ProtoNet P04839.
Proteomic databases
PeptideAtlas P04839; -.
Genome annotation databases
Ensembl ENSG00000165168; Homo sapiens. [Contig view]
GeneID 1536; -.
KEGG hsa:1536; -.
Phylogenomic databases
HOGENOM P04839; -.
HOVERGEN P04839; -.
Other
NextBio 6353; -.
SOURCE CYBB; Homo sapiens.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
Chronic granulomatous disease; Direct protein sequencing; Disease mutation; Electron transport; FAD; Glycoprotein; Heme; Ion transport; Ionic channel; Iron; Membrane; Metal-binding; NADP; Oxidoreductase; Polymorphism; Transmembrane; Transport; Voltage-gated channel.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom   To Length Description FTId
INIT_MET   1     1        Removed. 
CHAIN   2   570  569     Cytochrome b-245 heavy chain. PRO_0000210145
TOPO_DOM   2     8  7     Cytoplasmic (Potential). 
TRANSMEM   9    29  21     Potential. 
TOPO_DOM   30    48  19     Extracellular (Potential). 
TRANSMEM   49    69  21     Potential. 
TOPO_DOM   70   102  33     Cytoplasmic (Potential). 
TRANSMEM   103   123  21     Potential. 
TOPO_DOM   124   169  46     Extracellular (Potential). 
TRANSMEM   170   190  21     Potential. 
TOPO_DOM   191   200  10     Cytoplasmic (Potential). 
TRANSMEM   201   221  21     Potential. 
TOPO_DOM   222   261  40     Extracellular (Potential). 
TRANSMEM   262   282  21     Potential. 
TOPO_DOM   283   570  288     Cytoplasmic (Potential). 
DOMAIN   54   286  233     Ferric oxidoreductase. 
DOMAIN   287   397  111     FAD-binding FR-type. 
NP_BIND   338   344  7     FAD (Potential). 
METAL   101   101        Iron (heme axial ligand) (Probable). 
METAL   115   115        Iron (heme axial ligand) (Probable). 
METAL   209   209        Iron (heme axial ligand) (Probable). 
METAL   222   222        Iron (heme axial ligand) (Probable). 
CARBOHYD   132   132        N-linked (GlcNAc...) (Potential). 
CARBOHYD   149   149        N-linked (GlcNAc...) (Potential). 
CARBOHYD   240   240        N-linked (GlcNAc...) (Potential). 
VARIANT   18    18  1     W -> C (in X-CGD). VAR_047264 
VARIANT   20    20  1     G -> R (in X-CGD). VAR_007873 
VARIANT   41    41  1     Y -> D (in X-CGD). VAR_025613 
VARIANT   54    55  2     Missing (in X-CGD). VAR_047265
VARIANT   54    54  1     R -> M (in X-CGD). VAR_025614 
VARIANT   54    54  1     R -> S (in X-CGD). VAR_007874 
VARIANT   55    55  1     A -> D (in X-CGD). VAR_025615 
VARIANT   57    57  1     A -> E (in X-CGD). VAR_008845 
VARIANT   59    59  1     C -> R (in X-CGD). VAR_007875 
VARIANT   59    59  1     C -> W (in X-CGD). VAR_047266 
VARIANT   101   101  1     H -> R (in X-CGD). VAR_002432 
VARIANT   101   101  1     H -> Y (in X-CGD). VAR_007876 
VARIANT   119   119  1     H -> R (in X-CGD). VAR_007877 
VARIANT   156   156  1     A -> T (in X-CGD). VAR_002433 
VARIANT   179   179  1     G -> R (in X-CGD). VAR_047267 
VARIANT   193   193  1     S -> F (in X-CGD). VAR_047268 
VARIANT   205   205  1     F -> I (in X-CGD). VAR_047269 
VARIANT   209   209  1     H -> Q (in X-CGD). VAR_007878 
VARIANT   209   209  1     H -> R (in X-CGD). VAR_025616 
VARIANT   209   209  1     H -> Y (in X-CGD). VAR_002434 
VARIANT   215   215  1     Missing (in X-CGD). VAR_007879
VARIANT   222   222  1     H -> N (in X-CGD). VAR_007880 
VARIANT   222   222  1     H -> R (in X-CGD). VAR_007881 
VARIANT   222   222  1     H -> Y (in X-CGD). VAR_007882 
VARIANT   223   223  1     G -> L (in X-CGD; requires 2 nucleotide substitutions). VAR_007883 
VARIANT   224   224  1     A -> G (in X-CGD). VAR_025617 
VARIANT   225   225  1     E -> V (in X-CGD). VAR_002435 
VARIANT   244   244  1     C -> R (in X-CGD). VAR_007884 
VARIANT   244   244  1     C -> S (in X-CGD). VAR_002436 
VARIANT   244   244  1     C -> Y (in X-CGD). VAR_002437 
VARIANT   298   302  5     Missing (in X-CGD). VAR_047270
VARIANT   303   303  1     H -> N (in X-CGD; completely inhibits NADPH oxidase activity; NADPH oxidase assembly is abolished). VAR_016880 
VARIANT   304   304  1     P -> R (in X-CGD; reduces NADPH oxidase activity to 4% of wild-type; translocation to the membrane of the phagosome is only attenuated). VAR_016881 
VARIANT   307   307  1     T -> P (in X-CGD). VAR_047271 
VARIANT   309   309  1     E -> K (in X-CGD). VAR_007885 
VARIANT   315   315<